HemoSphere Alta advanced hemodynamic and cerebral monitoring during transplant and cardiac surgery
Official title: HemoSphere Alta Clinical Development Study
Run by Becton, Dickinson and Company · NCT07148323 · Data updated 2026-11-12
This project will test the HemoSphere Alta monitoring platform with a pulmonary artery catheter plus brain and hemodynamic sensors in adults having cardiac or liver transplant surgery who need advanced intraoperative monitoring.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Becton, Dickinson and Company Industry-sponsored |
| Locations | 1 site (Rochester, New York) |
| Status | Recruiting |
| Started | October 14, 2025 |
| Main results expected | November 2026 |
| Study ends | December 2026 |
| Registry record updated | August 26, 2026 |
| Trial ID | NCT07148323 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older scheduled for cardiac or liver transplant surgery lasting more than two hours with planned pulmonary artery catheter monitoring — including specified subcohorts for suspected right ventricular dysfunction or for cardiac surgery patients at high risk for cerebral vascular disease — are ideal candidates.
✕Probably not a fit
Patients who are under 18, who do not require invasive pulmonary artery catheter monitoring, or who undergo shorter or nonoperative procedures are unlikely to receive direct benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, non-randomized single-arm observational effort that collects device and physiologic data from adult patients monitored with the HemoSphere Alta platform and associated sensors during cardiac or liver transplant operations. Enrolled subjects will have planned pulmonary artery catheter monitoring and procedures expected to last more than two hours, with additional predefined sub-cohorts for possible right ventricular failure (based on pre-op TTE and planned intraoperative TEE) and for cerebral autoregulation impairment risk (older adults having cardiac surgery with cardiopulmonary bypass and placement of ForeSight IQ/Acumen IQ sensors). Data are collected intraoperatively and postoperatively for continual device development and algorithm refinement rather than to test a randomized intervention. The protocol documents device use, signal capture, and clinical context to support future product improvements.
Why it matters
Potential benefit: If successful, the collected data could help improve real-time hemodynamic and cerebral monitoring during high-risk cardiac and liver transplant procedures so clinicians detect and respond to instability earlier.
How similar studies have gone: Related monitoring technologies (pulmonary artery catheters, cerebral oximetry, and Acumen sensors) have been used clinically and studied previously with mixed but informative results, while collection of integrated Alta platform data for iterative device development is a newer, less-tested approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Signed informed consent 2. Age ≥ 18 years 3. Planned monitoring with a pulmonary artery catheter 4. Patient scheduled to undergo cardiac or liver transplant surgery lasting \> 2 hours 5. Additional criteria for Sub-Cohort A (RVF) 1. Possible Right Ventricular Dysfunction/Failure based on pre-operative assessment of previous Transthoracic Echocardiogram (TTE) 2. Planned Transesophageal Echocardiogram (TEE) assessment during the operative procedure 6. Additional criteria for Sub-Cohort B (CAI) 1. Age ≥ 45 years 2. Planned cardiac surgery with Cardiopulmonary Bypass (CPB) 3. Ability to place ForeSight IQ and Acumen IQ sensors during the operative monitoring period 4. High risk for cerebral vascular disease, defined as: a history of hypertension, pulse pressure \> 60 mmHg, diabetes, stroke, transient ischemic attack, carotid bruit, tobacco smoking, or peripheral vascular disease Exclusion Criteria: 1. Inability to provide informed consent 2. Pregnancy as confirmed per EMR 3. Patients deemed not suitable for the study at the discretion of the Investigator 4. Participation in another study that clinically interferes with the current study 5. Additional exclusion criteria for Sub-Cohort A 1. Presence of left bundle branch block 2. Presence of current/recurrent sepsis 3. Presence of hypercoagulability, as identified in the patient's past medical history and preoperative evaluation 4. Structural abnormality, including congenital heart defects, of the right ventricle 6. Additional exclusion criteria for Sub-Cohort B a. Surgery for congenital heart defect
Where it's running
-
University of Rochester Medical Center
Rochester, New York, United States Recruiting
Study contacts
- Study coordinator: Cristina Johnson
- Email: apmhsalta.study@bd.com
- Phone: 949-308-5850
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preoperative NPAR and Post-Induction Hemodynamic Vulnerability in Major Oncologic Surgery
This study checks if the preoperative neutrophil percentage-to-albumin ratio (NPAR) can flag who might become hemodynamically unstable after anesthesia induction in adults having major cancer surgery.
-
Pulse palpation vs arterial blood pressure in circulatory shock
This study tests how well feeling for a pulse at typical sites matches the actual arterial blood pressure in adults with circulatory shock or risk of failure.
-
Mindfulness-based breathing before spinal anesthesia for elective cesarean delivery
This trial will test whether a 5-minute mindfulness slow-breathing exercise just before spinal anesthesia can reduce blood pressure drops and anxiety in pregnant women having elective cesarean delivery.
-
Electrical stimulation plus isometric exercise to improve blood flow in resistant high blood pressure
This will try whether adding upper‑thoracic electrical stimulation (TENS) and isometric exercise to usual blood pressure medications can lower blood pressure and improve peripheral blood flow in men and women aged 50–60 with resistant hypertension.
-
Predicting fluid responsiveness using PLR, PPV, and LVOT VTI in ICU patients
In critically ill adults on ventilators, researchers test whether measuring LVOT VTI during a passive leg raise can help predict who will respond to fluid therapy.
-
Non-invasive continuous blood pressure monitoring during intracranial aneurysm coil embolization
This trial tests whether the ClearSight non‑invasive continuous blood pressure monitor can safely replace radial arterial catheter monitoring for adults having coil embolization of unruptured intracranial aneurysms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.